These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 1351932

  • 1. Dopamine efflux from striatum after chronic nicotine: evidence for autoreceptor desensitization.
    Harsing LG, Sershen H, Lajtha A.
    J Neurochem; 1992 Jul; 59(1):48-54. PubMed ID: 1351932
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differential regulation of release of acetylcholine in the striatum in mice following continuous exposure to selective D1 and D2 dopaminergic agonists.
    Wang HY, Zhou LW, Friedman E, Weiss B.
    Neuropharmacology; 1993 Jan; 32(1):85-91. PubMed ID: 8094235
    [Abstract] [Full Text] [Related]

  • 4. The actions of (-)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbens.
    Barnes JM, Barnes NM, Costall B, Naylor RJ.
    Neuropharmacology; 1990 Apr; 29(4):327-36. PubMed ID: 1971430
    [Abstract] [Full Text] [Related]

  • 5. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
    Hoffmann IS, Talmaciu RK, Ferro CP, Cubeddu LX.
    J Pharmacol Exp Ther; 1988 Jun; 245(3):761-72. PubMed ID: 3385641
    [Abstract] [Full Text] [Related]

  • 6. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Jun; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 7. [Chronic treatment with nicotine enhances the sensitivity of dopamine autoreceptors that modulate dopamine release from the rat striatum].
    Takaki T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Aug; 15(4):335-44. PubMed ID: 7584728
    [Abstract] [Full Text] [Related]

  • 8. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 9. Influence of dopamine on GABA release in striatum: evidence for D1-D2 interactions and non-synaptic influences.
    Harsing LG, Zigmond MJ.
    Neuroscience; 1997 Mar; 77(2):419-29. PubMed ID: 9472401
    [Abstract] [Full Text] [Related]

  • 10. Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice.
    L'hirondel M, Chéramy A, Godeheu G, Artaud F, Saiardi A, Borrelli E, Glowinski J.
    Brain Res; 1998 May 11; 792(2):253-62. PubMed ID: 9593923
    [Abstract] [Full Text] [Related]

  • 11. Modulation of [3H]-dopamine released by different frequencies of stimulation from rabbit retina.
    Dubocovich ML, Hensler JG.
    Br J Pharmacol; 1986 May 11; 88(1):51-61. PubMed ID: 3708223
    [Abstract] [Full Text] [Related]

  • 12. N-type calcium channels are involved in the dopamine releasing effect of nicotine.
    Harsing LG, Sershen H, Vizi SE, Lajtha A.
    Neurochem Res; 1992 Jul 11; 17(7):729-34. PubMed ID: 1328912
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: indications for a common signal transduction pathway.
    Drukarch B, Schepens E, Stoof JC.
    Neuroscience; 1990 Jul 11; 37(1):1-9. PubMed ID: 1978737
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of neurotensin and immunneutralization with anti-neurotensin-serum on dopaminergic-cholinergic interaction in the striatum.
    Töröcsik A, Rakovska A, Görcs T, Vizi ES.
    Brain Res; 1993 May 28; 612(1-2):306-12. PubMed ID: 8101133
    [Abstract] [Full Text] [Related]

  • 17. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O, Biggio G.
    Brain Res; 1990 Nov 12; 533(1):53-9. PubMed ID: 1982234
    [Abstract] [Full Text] [Related]

  • 18. Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis.
    LaHoste GJ, Marshall JF.
    Neuroscience; 1991 Nov 12; 41(2-3):473-81. PubMed ID: 1678501
    [Abstract] [Full Text] [Related]

  • 19. Release-regulating dopamine autoreceptors in human cerebral cortex.
    Fedele E, Andrioli GC, Ruelle A, Raiteri M.
    Br J Pharmacol; 1993 Sep 12; 110(1):20-2. PubMed ID: 8106101
    [Abstract] [Full Text] [Related]

  • 20. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May 12; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.